Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma [Phase 2, Phase 3]
Phase 2/3 trial update exploring optimized induction chemotherapy and concurrent chemoradiotherapy with reduced treatment intensity for naso…
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update for LONSURF in recurrent/metastatic nasopharyngeal carcinoma is reported, status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pembrolizumab in combination with vorinostat for recurrent, metastatic, or unresectable squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial evaluating toripalimab with concurrent chemoradiotherapy in unresectable locally recurrent nasopharyngeal carcinoma is curre…
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial comparing reduced versus conventional dosage intensity-modulated radiotherapy in chemotherapy-sensitive stage II-III nasopha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Treatment of Bevacizumab Followed by Steroid in RN [Phase 2]
Phase 2 clinical trial investigating bevacizumab followed by steroid for treatment of radiation-induced injury in nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 study evaluating camrelizumab plus apatinib in PD-1 antagonist–resistant recurrent/metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]
A phase 2 trial evaluating camrelizumab in combination with apatinib as first-line therapy for platinum-resistant recurrent/metastatic nasop…
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: A Phase II Clinical Study of Treprilimab in the Treatment of Recurrent Nasopharyngeal Carcinoma After Re-irradiation [Phase 2]
Phase II clinical trial update for Treprilimab in recurrent nasopharyngeal carcinoma after re-irradiation.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial comparing proton versus photon radiotherapy for nasopharyngeal carcinoma is ongoing with unclear status.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis [Phase 3]
Phase 3 trial investigating interleukin-11 for prevention and treatment of radioactive oral mucositis in nasopharyngeal carcinoma patients.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC [Phase 2]
Phase 2 clinical trial update for EBV-TCR-T (YT-E001) in EBV-positive recurrent or metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update evaluating concurrent chemoradiotherapy for stage II nasopharyngeal carcinoma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating concurrent chemoradiation with durvalumab for locoregionally advanced nasopharyngeal carcinoma (NPC).
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC [Phase 2]
Phase 2 clinical trial investigating Triprilimab (JS001) in combination with chemotherapy and local treatment for metastatic nasopharyngeal …
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 clinical trial evaluating induction chemotherapy plus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma is o…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients [Phase 3]
Phase III randomized trial investigating treatment strategies for nasopharyngeal carcinoma in the neoadjuvant setting.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial comparing chemotherapy combined with radiotherapy to chemotherapy alone for distant metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: Stereotactic Body Radiotherapy for Head and Neck Tumors [Phase 4]
Phase 4 clinical trial update on stereotactic body radiotherapy for head and neck tumors with completed status and posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating sufficient chemotherapy combined with maintenance chemotherapy for oligometastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours [Phase 2]
Phase 2 clinical trial evaluating denosumab as a model for rank-mediated immunologic modulation in virus-related nasopharyngeal carcinoma (E…
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC [Phase 2]
Phase 2 trial evaluating radical radiotherapy and chemotherapy with maintenance chemotherapy for Stage N3 nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating reduced target delineation and radiation doses with chemoradiotherapy for locoregionally advanced nasopharyngeal ca…
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial investigating concurrent chemotherapy for recurrent T3/T4 nasopharyngeal carcinoma; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer [Phase 2]
Phase 2 clinical trial of nivolumab in recurrent/metastatic nasopharyngeal cancer completed; results posted in 2019.